21 Maximizing Safety with Microneedling
10.1055/b-0040-177263 21 Maximizing Safety with MicroneedlingErez Dayan, David Dwayne Weir, Rod J. Rohrich, and E. Victor Ross Abstract Initially used in the treatment of scars, microneedling has been in use…
19 Maximizing Safety with Radiofrequency-Based Devices
10.1055/b-0040-177261 19 Maximizing Safety with Radiofrequency-Based DevicesErez Dayan and Rod J. Rohrich Abstract Radiofrequency (RF) energy delivered internally or externally has been successfully used to treat rhytids, jowling, skin laxity,…
20 Maximizing Safety with Cryolipolysis
10.1055/b-0040-177262 20 Maximizing Safety with CryolipolysisErez Dayan and Rod J. Rohrich Abstract Cryolipolysis is among the most popular noninvasive treatments for focal adipose excess. The FDA cleared cryolipolysis for reduction…
18 Trichloroacetic Acid Combined with Jessner’s Chemical Peel Safety
10.1055/b-0040-177260 18 Trichloroacetic Acid Combined with Jessner’s Chemical Peel SafetyErez Dayan and Rod J. Rohrich Abstract Trichloroacetic acid (TCA) is a versatile agent, efficacious in treating a spectrum of facial…
16 Maximizing Safety with Ablative Lasers
10.1055/b-0040-177258 16 Maximizing Safety with Ablative LasersE. Victor Ross, Erez Dayan, and Rod J. Rohrich Abstract Lasers are among the most precise and powerful tools available in facial rejuvenation. Through…
17 Maximizing Safety with Nonablative Lasers
10.1055/b-0040-177259 17 Maximizing Safety with Nonablative LasersE. Victor Ross, Erez Dayan, and Rod J. Rohrich Abstract Nonablative lasers are commonly used to treat a variety of conditions such as dyschromia,…
11 Facial Danger Zone 2 – Temporal Region
10.1055/b-0040-177253 11 Facial Danger Zone 2 – Temporal RegionRod J. Rohrich and Dinah Wan Abstract The superficial temporal artery and middle temporal vein lie within the temporal fossa in an…
10 Facial Danger Zone 1 – Glabellar Region
10.1055/b-0040-177252 10 Facial Danger Zone 1 – Glabellar RegionRod J. Rohrich and Dinah Wan Abstract The glabellar region is the most common filler injection site leading to blindness due to…
14 Facial Danger Zone 5 – Nasal Region
10.1055/b-0040-177256 14 Facial Danger Zone 5 – Nasal RegionRod J. Rohrich and Raja Mohan Abstract This chapter summarizes how to inject soft-tissue fillers into the nose. Many patients desire a…
15 Facial Danger Zone 6 – Infraorbital Region
10.1055/b-0040-177257 15 Facial Danger Zone 6 – Infraorbital RegionRod J. Rohrich and Raja Mohan Abstract This chapter summarizes how to inject soft-tissue fillers into the infraorbital region. Patients often report…
